Scientific paper - Review paper
N-3 PUFA and Pregnancy Preserve C-Peptide in Women with Type 1 Diabetes Mellitus
Pharmaceutics, 13 (2021), 12; 2082. https://doi.org/10.3390/pharmaceutics13122082


Cite this document

Đelmiš, J., Ivanišević, M. & Horvatiček, M. (2021). N-3 PUFA and Pregnancy Preserve C-Peptide in Women with Type 1 Diabetes Mellitus. Pharmaceutics, 13. (12). doi: 10.3390/pharmaceutics13122082

Đelmiš, Josip, et al. "N-3 PUFA and Pregnancy Preserve C-Peptide in Women with Type 1 Diabetes Mellitus." Pharmaceutics, vol. 13, no. 12, 2021. https://doi.org/10.3390/pharmaceutics13122082

Đelmiš, Josip, Marina Ivanišević and Marina Horvatiček. "N-3 PUFA and Pregnancy Preserve C-Peptide in Women with Type 1 Diabetes Mellitus." Pharmaceutics 13, no. 12 (2021). https://doi.org/10.3390/pharmaceutics13122082

Đelmiš, J., Ivanišević, M. and Horvatiček, M. (2021) 'N-3 PUFA and Pregnancy Preserve C-Peptide in Women with Type 1 Diabetes Mellitus', Pharmaceutics, 13(12). doi: 10.3390/pharmaceutics13122082

Đelmiš J, Ivanišević M, Horvatiček M. N-3 PUFA and Pregnancy Preserve C-Peptide in Women with Type 1 Diabetes Mellitus. Pharmaceutics [Internet]. 2021 December 04 [cited 2024 October 08];13(12). doi: 10.3390/pharmaceutics13122082

J. Đelmiš, M. Ivanišević and M. Horvatiček, "N-3 PUFA and Pregnancy Preserve C-Peptide in Women with Type 1 Diabetes Mellitus", Pharmaceutics, vol. 13, no. 12, December 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:385939. [Accessed: 08 October 2024]

Please login to the repository to save this object to your list.